Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine for Sleep and GI Recovery in Laparoscopic Uterine Surgery
NCT05715671Completed
- Start
- Mar 2023
- Primary completion
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of esketamine in sleep disorder and Postoperative gastrointestinal dysfunction (POGD) (3 arms). Primary endpoints: Changes in the level of actigraphy and Pittsburgh Sleep Quality Index. Started Mar 2023; status: completed.
02
Drugs
esketamine
03
Conditions
sleep disorderPostoperative gastrointestinal dysfunction (POGD)
Beyond the preview
Go deeper on NCT05715671.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05715671.